NS 11021
目录号 : GC10540
NS 11021是一种具有高效选择性的大电导钙激活钾通道（BKCa/KCa1.1）激活剂。
Cas No.:956014-19-0
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
NS 11021 is a highly potent and selective activator of large-conductance calcium-activated potassium channels (BKCa/KCa1.1)[1]. BKCa channels are present in various tissues such as neurons, smooth muscle, and mitochondria. They open in response to changes in membrane voltage and increases in intracellular calcium, facilitating rapid efflux of potassium (K+), which is crucial for regulating cellular excitability, muscle contraction, and neurotransmission[2,3]. NS 11021 is commonly used to investigate the physiological and pathological roles of BK channels in disease models related to cardiovascular regulation, neuronal excitability, and erectile dysfunction[4].
In vitro, pretreatment of primary hippocampal neurons from Fmr1 KO rats with NS 11021 (10µM) for 2min, followed by a 10-second 40-Hz stimulation, significantly restored the uptake of TMR-dextran and corrected deficits in activity-dependent bulk endocytosis (ADBE)[5]. Pretreatment of IGR39, Panc-1, and IGR37 cells with NS 11021 (20µM) for 72h markedly reduced cell viability and inhibited cell proliferation[6].
In vivo, a single intraperitoneal injection of NS 11021 (0.5mg/kg) in 1-month-old Atoh1-Pex5-/- mice significantly reduced auditory brainstem response thresholds and improved both the amplitude and latency of auditory brainstem response (ABR) wave I within 24h, effectively restoring hearing loss caused by peroxisome deficiency[7]. A single intravenous injection of NS 11021 (0.1mg/kg and 1mg/kg) in anesthetized Wistar rats significantly enhanced erectile responses induced by electrical stimulation of the cavernous nerve, an effect that was abolished by the administration of tetraethylammonium (TEA, 6mg/kg)[8].
References:
[1] KIRÁLY I, PATARICZA J, BAJORY Z, et al. Involvement of large-conductance Ca2+-activated K+ channels in both nitric oxide and endothelium-derived hyperpolarization-type relaxation in human penile small arteries[J]. Basic & Clinical Pharmacology & Toxicology, 2013, 113(1): 19-24.
[2] CHEN Y C, SHIH C L, WU C L, et al. Exploring the impact of BKCa channel function in cellular membranes on cardiac electrical activity[J]. International Journal of Molecular Sciences, 2024, 25(3): 1537.
[3] SINGH H, STEFANI E, TORO L. Intracellular BKCa (iBKCa) channels[J]. The Journal of Physiology, 2012, 590(23): 5937-5947.
[4] LAYNE J J, NAUSCH B, OLESEN S P, et al. BK channel activation by NS11021 decreases excitability and contractility of urinary bladder smooth muscle[J]. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010, 298(2): R378-R384.
[5] BONNYCASTLE K, KIND P C, COUSIN M A. FMRP sustains presynaptic function via control of activity-dependent bulk endocytosis[J]. Journal of Neuroscience, 2022, 42(8): 1618-1628.
[6] REMIGANTE A, ZUCCOLINI P, BARBIERI R, et al. NS-11021 modulates cancer-associated processes independently of BK channels in melanoma and pancreatic duct adenocarcinoma cell lines[J]. Cancers, 2021, 13(23): 6144.
[7] FU X, WAN P, LU L, et al. Peroxisome deficiency in cochlear hair cells causes hearing loss by deregulating BK channels[J]. Advanced Science, 2023, 10(20): 2300402.
[8] KUN A, MATCHKOV V V, STANKEVICIUS E, et al. NS11021, a novel opener of large-conductance Ca2+-activated K+ channels, enhances erectile responses in rats[J]. British Journal of Pharmacology, 2009, 158(6): 1465-1476.
NS 11021是一种具有高效选择性的大电导钙激活钾通道（BKCa/KCa1.1）激活剂[1]。BKCa存在于神经元、平滑肌和线粒体等多种组织中，可根据细胞膜电压的变化和细胞内钙的增加而打开，从而快速释放钾（K+），这对于调节细胞兴奋性、肌肉收缩和神经传递至关重要[2,3]。NS 11021通常用于心血管舒缩功能、神经元兴奋性调控以及勃起功能障碍等相关疾病模型中BK通道的生理与病理机制研究[4]。
在体外，NS 11021（10μM）预处理Fmr1 KO大鼠原代海马神经元2min，随后进行10s的40-Hz刺激，显著恢复了神经元中TMR-dextran的摄取并纠正了活动依赖的批量内吞（ADBE）功能缺陷[5]。NS 11021（20μM）预处理IGR39、Panc-1和IGR37细胞72h，显著降低了细胞活力并抑制了细胞增殖[6]。
在体内，NS 11021（0.5mg/kg）单次腹腔注射处理1月龄Atoh1-Pex5-/-小鼠，24h后可显著降低其听觉脑干反应阈值，并改善听性脑干反应（ABR）波I的振幅和潜伏期，有效恢复因过氧化物酶体缺陷导致的听力损失[7]。NS 11021（0.1mg/kg和1mg/kg）单次静脉注射给药麻醉的Wistar大鼠，可显著增强海绵体神经电刺激诱导的勃起反应，但该效应可被四乙胺（TEA, 6mg/kg）消除[8]。
| Cell experiment [1]: | |
Cell lines | Hippocampal neurons (from Fmr1 KO rats) |
Preparation Method | Hippocampal neurons from Fmr1 KO rats were incubated with 10μM NS 11021 and 50μM TMR-dextran for 2min before a 40-Hz 10-s stimulus on DIV13–DIV15. The TMR-dextran solution was immediately washed away after stimulation terminated, and images were acquired using 556/25-nm excitation and 630/98-nm emission bandpass filters while undergoing constant perfusion. |
Reaction Conditions | 10μM; 2min |
Applications | NS 11021 treatment significantly restored TMR-dextran uptake in neurons and corrected ADBE deficits. |
| Animal experiment [2]: | |
Animal models | Wistar rat |
Preparation Method | NS 11021 (0.1 and 1mg/kg) was administered after establishing a maximal (10Hz, 1ms, 6V) and submaximal response (10Hz, 1ms, 0.6 to 1.55V) to cavernous nerve stimulation for 30s. Submaximal stimulation was repeated 3, 13 and 23min after drug administration. For each electrically induced erectile response, the ratio peak intracavernosal pressure (PICP) (mmHg)/MAP (mmHg) × 100 was measured. |
Dosage form | 0.1 and 1mg/kg; i.p. |
Applications | Treatment with NS 11021 can significantly enhance erectile responses induced by electrical stimulation of the corpus cavernosum nerves. |
References: | |
| Cas No. | 956014-19-0 | SDF | |
| 化学名 | 1-(3,5-bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(2H-tetrazol-5-yl)phenyl)thiourea | ||
| Canonical SMILES | BrC1=CC=C(C(C2=NNN=N2)=C1)NC(NC3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)=S | ||
| 分子式 | C16H9BrF6N6S | 分子量 | 511.24 |
| 溶解度 | DMF: 15 mg/mL,DMF:PBS (pH 7.2)(1:3): 0.25 mg/mL,DMSO: 10 mg/mL,Ethanol: 0.3 mg/mL | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.956 mL | 9.7801 mL | 19.5603 mL |
| 5 mM | 391.2 μL | 1.956 mL | 3.9121 mL |
| 10 mM | 195.6 μL | 978 μL | 1.956 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet